You are here

Japan biotech venture PeptiDream a US$3b business

BT_20160621_CPSUGA21_2344378.jpg
Mr Kubota (right) and Prof Suga, whose lab developed an artificial ribozyme, which he named flexizyme for its "promiscuous" ability to help amino acids couple to form peptides.

Tokyo

WHEN he realised he wasn't going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.

Many years spent fiddling with the building blocks of the universe - combining molecules to form compounds - led

sentifi.com

Market voices on:

grab

Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at btsub.sg/promo

Powered by GET.comGetCom